EUVIMEDEUVIMED entdecken
Crossref

Hepatocellular carcinoma-derived protein encapsulated iron oxide/black phosphorus nanosheets for targeted photothermal-chemotherapy

Danhong Yan, Chaiqiong Guo, Yang Wang iD, Yan Wei iD

Biomedical Materials · 2025

DOI: 10.1088/1748-605x/adebd1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, 2025. Verfasst von Danhong Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Suzhou Chien-shiung Institute of Technology, Taicang 215411, Jiangsu Province, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Phosphorus, Photothermal Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, China, Science and Technology Planning Project of Taicang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In cancer treatment, single modalities such as chemotherapy or photothermal therapy (PTT) often face significant limitations, leading to suboptimal therapeutic outcomes. In recent years, the combination of chemotherapy and PTT has garnered significant attention as a promising approach for enhancing cancer treatment efficacy. In this study, we designed a nanodrug delivery system based on black phosphorus nanosheets (BPNS) and Fe 3 O 4 composites, incorporating molecular and magnetic targeting strategies. The system loaded the small-molecule anticancer drug RSL3 and was encapsulated with hepatocellular carcinoma cell membrane proteins to form the Pro@Fe 3 O 4 /BPNS-RSL3 composite nanosystem. The goal was to enhance targeted chemo-photothermal combination therapy. The physical and chemical properties, photothermal performance and stability, drug release kinetics, in vitro cellular uptake, cell compatibility, and synergistic therapeutic effects were all evaluated. The results demonstrated that the composite nanosystem exhibited excellent photothermal performance and stability. After 72 h at pH 5.5, the cumulative release of RSL3 reached 69.93%, indicating a faster and higher drug release profile under acidic conditions. In vitro cell uptake experiments showed significantly higher uptake by liver cancer cells (Huh7) compared to normal cells (LO2), suggesting that the system effectively targets liver cancer cells. Additionally, in vitro synergistic therapeutic results revealed that the composite nanosystem reduced the survival rate of liver cancer cells to less than 15%. Western blot analysis further confirmed that the system downregulated the expression of FACL4, Ferritin, and GPX4, thereby promoting the ferroptosis of cancer cells. Overall, the findings highlight that this nanosystem exhibits remarkable cancer cell-killing effects and offers a promising novel strategy for tumor therapy. Its potential for application in cancer treatment is significant, providing a new avenue for more effective and targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPhosphorusPhotothermal TherapyFerric CompoundsHumansCell Line, TumorAntineoplastic AgentsPhototherapyDrug Delivery SystemsCombined Modality TherapyCell SurvivalDrug LiberationNanostructures

Stichwörter der Autor:innen

black phosphorusferroptosishepatocellular carcinomairon oxidephotothermal-chemotherapy

Substanzen

PhosphorusAntineoplastic Agentsferric oxideFerric Compounds

Autor:innen und Institutionen

  • Department of Medical Technology, Suzhou Chien-shiung Institute of Technology, Taicang 215411, Jiangsu Province, People's Republic of China.
  • Department of Biomedical Engineering, Research Center for Nano-Biomaterials & Regenerative Medicine, College of Artificial Intelligence, Taiyuan University of Technology, Taiyuan 030024, People's Republic of China.

ORCID-Profile: Yang Wang, Yan Wei

Förderung

  • Natural Science Foundation of Shanxi Province, China
  • Science and Technology Planning Project of Taicang

Zitieren

APA

Yan, D., Guo, C., Wang, Y., & Wei, Y. (2025). Hepatocellular carcinoma-derived protein encapsulated iron oxide/black phosphorus nanosheets for targeted photothermal-chemotherapy. Biomedical Materials. https://doi.org/10.1088/1748-605x/adebd1

Vancouver

Yan D, Guo C, Wang Y, Wei Y. Hepatocellular carcinoma-derived protein encapsulated iron oxide/black phosphorus nanosheets for targeted photothermal-chemotherapy. Biomedical Materials. 2025. doi:10.1088/1748-605x/adebd1

BibTeX
@article{Yan2025,
  author = {Yan, Danhong and Guo, Chaiqiong and Wang, Yang and Wei, Yan},
  title = {Hepatocellular carcinoma-derived protein encapsulated iron oxide/black phosphorus nanosheets for targeted photothermal-chemotherapy},
  journal = {Biomedical Materials},
  year = {2025},
  doi = {10.1088/1748-605x/adebd1}
}
Kostenlos starten →